Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

Direct Payment

$100,000.00

Control of ESX-1 virulence secretion by the espA-espC-espD operon in Mycobacterium tuberculosis: molecular characterization and potential for anti-virulence drug development.

EF 2009-10

Résumé
Mycobacterium tuberculosis (M. tb) inflicts enormous human suffering. Every year, two million individuals die and eight million more are infected by this deadly air-borne pathogen. Exacerbating this grim statistic is the proliferation of multi- and extensively drug resistant TB strains. Novel anti-TB drugs, safe from evolved resistance, are urgently needed. M. tb's success as an intracellular pathogen relies on its secretion of potent effector proteins EsxA and EsxB, through a type VII secretion apparatus known as ESX-1. Genetic mutants of components of ESX-1 are greatly attenuated. Hence despite its non-essentiality, ESX-1 is an attractive target for anti-TB drug development. Crucial roles for previously uncharacterized EspA, EspC and EspD proteins have recently been identified in ESX-1 function; however the molecular basis of this essentiality remain poorly defined. My investigations so far indicate EspA is an ESX-1 dependent secreted protein which accumulates at the M. tb cell membrane and cell wall before translocation. EspA is also highly unstable, and requires co-expression with EspC and EspD to chaperone EspA, thereby stabilizing it and facilitate ESX-1 function. Moreover EspC and EspD are also secreted proteins, with only the former being dependent on ESX-1. These findings are beginning to reveal the functional capacities of EspA, EspC and EspD in ESX-1 function but questions remain. As secreted proteins, do EspA, EspC and EspD have additional properties? How is EspD translocated? Does the dynamics of expression and cellular localization of EspA, EspC, EspD and ESX-1 components change under conditions mimicking the intracellular environment of an activated macrophage? Most importantly, can this knowledge be exploited for the discovery of small molecules that block ESX-1 and abrogate virulence? Chemical genetics, structural biology, molecular and cellular microbiology methods are being used to answer these questions.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Switzerland
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
203274
Name
Chen Jeffrey M
Country
Switzerland
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Control of ESX-1 virulence secretion by the espA-espC-espD operon in Mycobacterium tuberculosis: molecular characterization and potential for anti-virulence drug development.
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cellular Microbiology; Chemical Biology; Chemical Genetics; Functional Genomics; Molecular Mycobacteriology; Mycobacterial Genetics; Mycobacterial Pathogenesis; Protein Biochemistry; Proteomics; Structural Biology
Abstract
Mycobacterium tuberculosis (M. tb) inflicts enormous human suffering. Every year, two million individuals die and eight million more are infected by this deadly air-borne pathogen. Exacerbating this grim statistic is the proliferation of multi- and extensively drug resistant TB strains. Novel anti-TB drugs, safe from evolved resistance, are urgently needed. M. tb's success as an intracellular pathogen relies on its secretion of potent effector proteins EsxA and EsxB, through a type VII secretion apparatus known as ESX-1. Genetic mutants of components of ESX-1 are greatly attenuated. Hence despite its non-essentiality, ESX-1 is an attractive target for anti-TB drug development. Crucial roles for previously uncharacterized EspA, EspC and EspD proteins have recently been identified in ESX-1 function; however the molecular basis of this essentiality remain poorly defined. My investigations so far indicate EspA is an ESX-1 dependent secreted protein which accumulates at the M. tb cell membrane and cell wall before translocation. EspA is also highly unstable, and requires co-expression with EspC and EspD to chaperone EspA, thereby stabilizing it and facilitate ESX-1 function. Moreover EspC and EspD are also secreted proteins, with only the former being dependent on ESX-1. These findings are beginning to reveal the functional capacities of EspA, EspC and EspD in ESX-1 function but questions remain. As secreted proteins, do EspA, EspC and EspD have additional properties? How is EspD translocated? Does the dynamics of expression and cellular localization of EspA, EspC, EspD and ESX-1 components change under conditions mimicking the intracellular environment of an activated macrophage? Most importantly, can this knowledge be exploited for the discovery of small molecules that block ESX-1 and abrogate virulence? Chemical genetics, structural biology, molecular and cellular microbiology methods are being used to answer these questions.
Competitiondate
201002
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Chen, Jeffrey M
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $100,000~ $0~